✦ LIBER ✦

PND39 PATIENT- AND PHYSICIAN-ASSESSED FUNCTIONAL DISABILITY IN PATIENTS TREATED WITH BOTULINUM TOXIN TYPE A FOR CERVICAL DYSTONIA

✍ Scribed by T Bramley; MV Shah; R Carlton

Book ID: 118609166
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 92 KB
Volume: 11
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)70472-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Botulinum toxin type A therapy in a pati

Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis

✍ Carlos Singer; Spiridon Papapetropaulos; D. Ram Ayyar; Ashok Verma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

Autonomic cardiovascular function and ba

Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type A

✍ D. Tiple; S. Strano; C. Colosimo; G. Fabbrini; G. Calcagnini; M. Prencipe; A. Be 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 256 KB

PND37 REDUCTIONS IN FREQUENCY AND INTENS

PND37 REDUCTIONS IN FREQUENCY AND INTENSITY OF PAIN WITH BOTULINUM TOXIN TYPE A FOR THE TREATMENT OF CERVICAL DYSTONIA

✍ MV Shah; R Carlton; T Bramley 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Severity and impact of xerostomia in pat

Severity and impact of xerostomia in patients treated with botulinum toxin type b for cervical dystonia: Observations on the quality of life of patients with xerostomia

✍ Patrick Hogan; P.David Charles; Maureen Wooten Watts; Janice M. Massey; Tamara M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Botulinum toxin type B vs. type A in tox

Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial

✍ Eric J. Pappert; Terry Germanson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract The objective of this study was to compare efficacy, safety, and duration of botulinum toxin type A (BoNT‐A) and type B (BoNT‐B) in toxin‐naïve cervical dystonia (CD) subjects. BoNT‐naïve CD subjects were randomized to BoNT‐A or BoNT‐B and evaluated in a double‐blind trial at baseline a

1.298 CHANGES IN SENSORIMOTOR NETWORK AC

1.298 CHANGES IN SENSORIMOTOR NETWORK ACTIVATIONS AFTER BOTULINUM TOXIN TYPE A INJECTIONS IN PATIENTS WITH CERVICAL DYSTONIA. A FUNCTIONAL MRI STUDY

✍ M. Nevrly; P. Hlustik; P. Otruba; R. Opavsky; P. Hok; P. Kaňovský 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB